查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1413076

黴漿菌檢測市場：按產品/服務、技術、應用和最終用戶分類 - 全球預測 2024-2030

Mycoplasma Testing Market by Product & Service (Assays, Kits, & Reagents, Instruments, Services), Technique (Enzyme-Linked Immunosorbent Assay, Nucleic Acid Testing, Staining), Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

黴漿菌檢測市場規模預計2023年為7.9711億美元，預計2024年將達到8.6545億美元，2030年將達到14.5598億美元，複合年成長率為8.98%。

全球黴漿菌檢測市場

主要市場統計
基準年[2023] 7.9711 億美元
預測年份 [2024] 8.6545億美元
預測年份 [2030] 1,455,980,000 美元
複合年成長率（%） 8.98%
支原體檢測市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估黴漿菌檢測市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出資訊的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對黴漿菌測試市場中供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更資訊的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-黴漿菌檢測市場的市場規模和預測是多少？

2-黴漿菌測試市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些？

3-黴漿菌檢測市場的技術趨勢和法律規範是什麼？

4-黴漿菌檢測市場主要供應商的市場佔有率是多少？

5-進入黴漿菌檢測市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 細胞培養物污染增加所導致的需求
      • 擴大藥品研發活動及投資
      • 對快速、準確且經濟實惠的測試的需求不斷成長
    • 抑制因素
      • 培養基某些成分的品質可能會影響較長的測試時間和培養基測定的靈敏度。
    • 機會
      • 加強生命科學研究
      • 新興國家細胞培養在病毒學的應用
    • 任務
      • 需要先進的測試專業知識
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章黴漿菌檢測市場（依產品及服務）

  • 測定、套件和試劑
  • 裝置
  • 服務

第7章黴漿菌檢測市場：依技術分類

  • 酵素免疫分析法
  • 核酸檢測
  • 染色

第8章黴漿菌檢測市場：依應用分類

  • 細胞株測試
  • 測試壽命終止的細胞
  • 病毒檢測

第9章黴漿菌檢測市場：依最終用戶分類

  • 學術研究所
  • 細胞庫和實驗室
  • 合約研究組織
  • 製藥和生物技術公司

第10章美洲黴漿菌檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區黴漿菌檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲黴漿菌檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：按主要企業分類
  • 主要企業競爭情境分析

第14章競爭產品組合

  • 主要公司簡介
    • Agilent Technologies, Inc.
    • Bionique Testing Laboratories, Inc.
    • Charles River Laboratories International, Inc.
    • Creative Bioarray
    • Eurofins Scientific SE
    • F. Hoffmann-La Roche AG
    • Genecopoeia, Inc.
    • InvivoGen
    • Merck KGaA
    • Meridian Bioscience, Inc.
    • Minerva Biolabs GmbH
    • Mycoplasma Experience Limited
    • Nelson Laboratories Fairfield, Inc.
    • Norgen Biotek Corporation
    • Promocell GmbH
    • Savyon Diagnostics
    • Thermo Fisher Scientific, Inc.
  • 主要產品系列

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-FB6C9E793503

[188 Pages Report] The Mycoplasma Testing Market size was estimated at USD 797.11 million in 2023 and expected to reach USD 865.45 million in 2024, at a CAGR 8.98% to reach USD 1,455.98 million by 2030.

Global Mycoplasma Testing Market

KEY MARKET STATISTICS
Base Year [2023] USD 797.11 million
Estimated Year [2024] USD 865.45 million
Forecast Year [2030] USD 1,455.98 million
CAGR (%) 8.98%
Mycoplasma Testing Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Mycoplasma Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Mycoplasma Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Mycoplasma Testing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Bionique Testing Laboratories, Inc., Charles River Laboratories International, Inc., Creative Bioarray, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Genecopoeia, Inc., InvivoGen, Merck KGaA, Meridian Bioscience, Inc., Minerva Biolabs GmbH, Mycoplasma Experience Limited, Nelson Laboratories Fairfield, Inc., Norgen Biotek Corporation, Promocell GmbH, Savyon Diagnostics, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Mycoplasma Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product & Service
    • Assays, Kits, & Reagents
    • Instruments
    • Services
  • Technique
    • Enzyme-Linked Immunosorbent Assay
    • Nucleic Acid Testing
    • Staining
  • Application
    • Cell Line Testing
    • End-Of-Production Cell Testing
    • Virus Testing
  • End-User
    • Academic & Research Institutes
    • Cell Banks & Laboratories
    • Contract Research Organizations
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Mycoplasma Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Mycoplasma Testing Market?

3. What are the technology trends and regulatory frameworks in the Mycoplasma Testing Market?

4. What is the market share of the leading vendors in the Mycoplasma Testing Market?

5. Which modes and strategic moves are suitable for entering the Mycoplasma Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Mycoplasma Testing Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Demand due to rise in cell culture contamination
      • 5.1.1.2. Growing R&D activities and investments by pharmaceuticals
      • 5.1.1.3. Increasing demand for fast, accurate, and affordable testing
    • 5.1.2. Restraints
      • 5.1.2.1. Long testing time and sensitivity of the media assay can be influenced by the quality of the particular components of the medium
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing efforts towards life science research
      • 5.1.3.2. Use of cell culture in virology for developing countries
    • 5.1.4. Challenges
      • 5.1.4.1. Requirement of high laboratory expertise
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Mycoplasma Testing Market, by Product & Service

  • 6.1. Introduction
  • 6.2. Assays, Kits, & Reagents
  • 6.3. Instruments
  • 6.4. Services

7. Mycoplasma Testing Market, by Technique

  • 7.1. Introduction
  • 7.2. Enzyme-Linked Immunosorbent Assay
  • 7.3. Nucleic Acid Testing
  • 7.4. Staining

8. Mycoplasma Testing Market, by Application

  • 8.1. Introduction
  • 8.2. Cell Line Testing
  • 8.3. End-Of-Production Cell Testing
  • 8.4. Virus Testing

9. Mycoplasma Testing Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Cell Banks & Laboratories
  • 9.4. Contract Research Organizations
  • 9.5. Pharmaceutical & Biotechnology Companies

10. Americas Mycoplasma Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Mycoplasma Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Mycoplasma Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Agilent Technologies, Inc.
    • 14.1.2. Bionique Testing Laboratories, Inc.
    • 14.1.3. Charles River Laboratories International, Inc.
    • 14.1.4. Creative Bioarray
    • 14.1.5. Eurofins Scientific SE
    • 14.1.6. F. Hoffmann-La Roche AG
    • 14.1.7. Genecopoeia, Inc.
    • 14.1.8. InvivoGen
    • 14.1.9. Merck KGaA
    • 14.1.10. Meridian Bioscience, Inc.
    • 14.1.11. Minerva Biolabs GmbH
    • 14.1.12. Mycoplasma Experience Limited
    • 14.1.13. Nelson Laboratories Fairfield, Inc.
    • 14.1.14. Norgen Biotek Corporation
    • 14.1.15. Promocell GmbH
    • 14.1.16. Savyon Diagnostics
    • 14.1.17. Thermo Fisher Scientific, Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. MYCOPLASMA TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. MYCOPLASMA TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. MYCOPLASMA TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. MYCOPLASMA TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. MYCOPLASMA TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. MYCOPLASMA TESTING MARKET DYNAMICS
  • FIGURE 7. MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
  • FIGURE 8. MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 10. MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. MYCOPLASMA TESTING MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. MYCOPLASMA TESTING MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. MYCOPLASMA TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. MYCOPLASMA TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MYCOPLASMA TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 6. MYCOPLASMA TESTING MARKET SIZE, BY ASSAYS, KITS, & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. MYCOPLASMA TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. MYCOPLASMA TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 10. MYCOPLASMA TESTING MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. MYCOPLASMA TESTING MARKET SIZE, BY NUCLEIC ACID TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. MYCOPLASMA TESTING MARKET SIZE, BY STAINING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. MYCOPLASMA TESTING MARKET SIZE, BY CELL LINE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. MYCOPLASMA TESTING MARKET SIZE, BY END-OF-PRODUCTION CELL TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. MYCOPLASMA TESTING MARKET SIZE, BY VIRUS TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. MYCOPLASMA TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. MYCOPLASMA TESTING MARKET SIZE, BY CELL BANKS & LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. MYCOPLASMA TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. MYCOPLASMA TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES MYCOPLASMA TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA MYCOPLASMA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM MYCOPLASMA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. MYCOPLASMA TESTING MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 191. MYCOPLASMA TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. MYCOPLASMA TESTING MARKET LICENSE & PRICING